Prolactinoma

Last updated: November 01, 2022

Prolactinoma

Endo

Endo

Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Hyperthyroidism
Hyperthyroidism medications
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Thyroglossal duct cyst
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetic retinopathy
Diabetic nephropathy
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Polycystic ovary syndrome
Multiple endocrine neoplasia
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Carcinoid syndrome
Pheochromocytoma
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Diabetes mellitus: Clinical
Hypothyroidism and thyroiditis: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Thyroid nodules and thyroid cancer: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism: Clinical
Cushing syndrome: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
MEN syndromes: Clinical
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Glucocorticoids
Precocious and delayed puberty: Clinical
Infertility: Clinical
Virilization: Clinical
Osteoporosis
Bone disorders: Pathology review
Osteomalacia and rickets
Paget disease of bone
Synthesis of adrenocortical hormones

Transcript

Watch video only

With prolactinoma, prolactin refers to the endocrine hormone secreted by the pituitary gland and -oma refers to a tumor.

So a prolactinoma is a benign tumor, or adenoma, of the pituitary gland that secretes excess prolactin.

Normally, the pituitary is a pea-sized gland, hanging by a stalk from the base of the brain.

It sits just behind the eyes near something called the optic chiasm, which is where the optic nerves cross.

The anterior pituitary, which is the front of the pituitary gland, contains a few different types of cells, and each of which secretes a different hormone.

One group of cells in the anterior pituitary are called lactotrophs and they secrete prolactin.

Prolactin stimulates breast milk production.

Another group of cells are the gonadotrophs and they secrete two gonadotropic hormones - luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH, both of which stimulate the ovaries in women which make estrogen and stimulate the testes in men which make testosterone.

Prolactin release is controlled by something called the hypothalamus, which is a structure at the base of the brain just above the pituitary gland.

It makes two key hormones, thyrotropin-releasing hormone which increases prolactin release, and dopamine, which inhibits the prolactin release and actually overrides the stimulatory effect of thyrotropin-releasing hormone.

That’s why dopamine is known as prolactin-inhibiting factor, and why it’s constantly released to prevent prolactin release in anyone that’s not pregnant.

High levels of prolactin in the blood sends a negative feedback signal to the hypothalamus, making it release more dopamine which then decreases prolactin levels.

High levels of prolactin can also signal the hypothalamus to decrease the secretion of gonadotropin releasing hormone or GnRH.

Gonadotropin releasing hormone acts on the anterior pituitary to make follicle stimulating hormone and luteinizing hormone or FSH and LH.

Now, during pregnancy the anterior pituitary gland releases prolactin and the placenta releases human placental lactogen and progesterone, and all three of these hormones stimulate the growth of more glandular tissue in the breast to produce milk.

Prolactinomas are functional tumors, meaning they secrete high levels of prolactin, and they typically form when there’s a mutation in the lactotroph cells of the anterior pituitary that allows the cells to divide uncontrollably.

The key is in the size of these things. Prolactinomas that are less than 10 mm in diameter are considered microprolactinomas, whereas those greater than 10 mm are known as macroprolactinomas.

Now, macroprolactinomas can compress surrounding structures like the meninges, which is the protective layer overlying the brain and that typically causes pain when it’s stretched.

Also, an enlarged pituitary gland can compress the optic nerves as they cross at the optic chiasm.

This can cause visual problems as well as affect a person’s ability to view things that are in the temporal, or the outermost portion, of the visual field in both eyes, and this is called “bitemporal hemianopia”.

Another name for this is tunnel vision because the center of your vision is clear but everything in the periphery is dark, kind of like looking through a tunnel, I suppose.

Key Takeaways

A prolactinoma is a benign pituitary gland tumor that produces high levels of the hormone prolactin. Prolactin then suppresses the gonadotropin-releasing hormone resulting in symptoms like amenorrhea, galactorrhea, hypogonadism, gynecomastia, and erectile dysfunction in males. Treatment involves the use of dopamine agonist agents like bromocriptine which reduces the size of the tumor and lowers prolactin levels. In some cases, surgery or radiation therapy may also be required.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy" Nature Clinical Practice Endocrinology & Metabolism (2006)
  7. "Demographic differences in incidence for pituitary adenoma" Pituitary (2010)